Double Blind

A stroke is like a brush fire in the brain, burning over a million neurons per minute. But one Canadian doctor is out to prove his drug can stop it in its tracks.

Project Details

Release Date

March 2019

Content Component(s)

Electronic Book or Magazine
TV One-Off
Webisodes

Episode(s)

1 x 60 mins

Genre(s)

Documentary

Target Audience(s)

Adults
Seniors

Health & Wellness Subject Area(s)

Chronic Disease Management

A sudden stroke is like a brush fire in the brain, burning over a million neurons per minute. For the victim, every passing second without intervention means more debilitating neurological damage. Or even death.  But one Canadian doctor has developed a drug he is convinced can stop an ischemic stroke in its tracks.  To prove it, Dr. Michael Tymianski has founded his own biotech company, raised private money, and is conducting two phase-3 drug trials in humans. ‘Double Blind’ follows the trials to their high-stakes moment of truth. Failure would spell the loss of decades of research and millions of dollars. Success would mean improving the lives of millions who suffer stroke worldwide and represent the biggest Canadian medical innovation since the discovery of insulin.

Antica Productions Ltd.

For years, Antica has produced engaging, entertaining and nation-building content. We’ve proven that our TV, digital, podcast and branded entertainment can help start important national conversations. From big studio shows and intimate films, to docs covering everything from science, music and sports…we’re getting people talking. Contact for Queries page

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.